SCHEMBL4057157

SCHEMBL4057157

CCN1CC[C@@H](c2c3n(c4ccccc24)S(=O)(=O)c2ccccc2-3)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.46
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
CA12 O43570 2/20 0.36
CA9 Q16790 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HTR1A P08908 1/20 0.35
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
SRC P12931 1/20 0.34
PRKCA P17252 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14177897 1.00 HTR6 (0.46) HTR6ALDH1A1MAPTCA12CA9
SCHEMBL4053320 1.00 HTR6 (0.46) HTR6ALDH1A1MAPTCA12CA9
SCHEMBL4049883 0.87 HTR6 (0.46) HTR6ALDH1A1MAPT
SCHEMBL4049266 0.87 HTR6 (0.46) HTR6ALDH1A1MAPT
SCHEMBL14177901 0.87 HTR6 (0.46) HTR6ALDH1A1MAPT
SCHEMBL4058603 0.86 HTR6 (0.53) HTR6ALDH1A1MAPTHTR1AADRA1D
SCHEMBL5785901 0.86 HTR6 (0.53) HTR6ALDH1A1MAPTHTR1AADRA1D
SCHEMBL4047803 0.86 HTR6 (0.53) HTR6ALDH1A1MAPTHTR1AADRA1D
SCHEMBL4050240 0.85 HTR6 (0.43) HTR6ALDH1A1ADRA1DADRA1AADRA1B
SCHEMBL4057234 0.85 HTR6 (0.43) HTR6ALDH1A1ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1704154-B1 NOVEL INDENO [2,1A]INDENES AND ISOINDOL [2,1-A]INDOLES SUVEN LIFE SCIENCES LTD (IN) 2009-05-06 EP claimed
US-7388024-B2 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2008-06-17 US claimed
US-20070054946-A1 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2007-03-08 US claimed
EP-1704154-A1 NOVEL INDENO [2,1A]INDENES AND ISOINDOL [2,1-A]INDOLES Suven Life Sciences Limited (IN) 2006-09-27 EP claimed
WO-2005066184-A1 NOVEL INDENO[2,1A]INDENES AND ISOINDOL[2,1-A]INDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2005-07-21 WO claimed
EP-1704154-B1 NOVEL INDENO [2,1A]INDENES AND ISOINDOL [2,1-A]INDOLES SUVEN LIFE SCIENCES LTD (IN) 2009-05-06 EP disclosed
US-7388024-B2 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2008-06-17 US disclosed
US-20070054946-A1 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054946-A1 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles IDO1, IDO2, OPRD1 HTR6 166/4885ALDH1A1 547/4885MAPT 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.